by defeatmsa | Sep 27, 2021 | Medical Research
VERY DISAPPOINTING NEWS FROM BIOHAVEN RE: VERDIPERSTAT (& M-STAR STUDY) Biohaven remains committed to neuroscience and to the MSA community. They intend to analyze the results further. Biohaven has met with Defeat MSA Alliance all along in this process and...
by defeatmsa | Sep 27, 2021 | Advocacy Blog, Advocate's Blog, Documentary
DEFEAT MSA ALLIANCE is pleased to announce the WORLD PREMIERE of a new documentary from New Zealand: “GLIMPSES” on Saturday, Oct 2, 2021 on the last day of the Second Annual All-Community Virtual Conference in honor of WORLD MSA DAY – OCTOBER 3,...
by defeatmsa | Sep 26, 2021 | Medical Research
Disappointing News from Theravance in Press Release: —- Theravance Biopharma, Inc. Announces Top-line Results from a Phase 3 Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension September 15, 2021 at 6:05 AM EDT PDF Version...
Recent Comments